Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SkaaltecCompany profile Skaaltec develops wearable vagus nerve stimulation technology that pairs stimulation with movement to support stroke rehabilitation research. Skaaltec develops wearable vagus nerve stimulation technology that pairs stimulation with movement to support stroke rehabilitation research. | Undisclosed | Future of Health Grant Level 2Undisclosed | Healthtech | Switzerland | Investors | |
| PM Prevision MedicineCompany profile Tests living patient cancer cells against drugs and combinations to help oncologists compare treatment options. Tests living patient cancer cells against drugs and combinations to help oncologists compare treatment options. | Undisclosed | Future of Health Grant Level 2 supportUndisclosed | Healthtech | Switzerland | Investors | |
| LH Lyv HealthcareCompany profile Lyv Healthcare develops digital support for people with endometriosis, combining symptom tracking and structured non-drug programmes alongside medical care. Lyv Healthcare develops digital support for people with endometriosis, combining symptom tracking and structured non-drug programmes alongside medical care. | Undisclosed | Future of Health Grant Level 3Undisclosed | Healthtech | France | Investors | |
| V VastCompany profile Developing next-generation space stations to ensure continuous human presence in space Developing next-generation space stations to ensure continuous human presence in space | $500M | Series A+DebtUndisclosed | Space tech | United States | Investors | |
AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $9M | BioMaP project agreement expansionUndisclosed | Biotech | United States | Investors Undisclosed | |
| P PasqalCompany profile Pasqal develops quantum processors that use laser-controlled neutral atoms, with systems and algorithms for industrial and research customers. Pasqal develops quantum processors that use laser-controlled neutral atoms, with systems and algorithms for industrial and research customers. | $250M | Convertible financingUndisclosed | Hardware | France | Investors Undisclosed | |
| C CyclopsCompany profile Cyclops enables payments companies to onboard with a single partner, unlocking stablecoin settlement, payins, payouts and treasury optimization across global corridors Cyclops enables payments companies to onboard with a single partner, unlocking stablecoin settlement, payins, payouts and treasury optimization across global corridors | $8M | StrategicUndisclosed | Fintech | United States | Investors | |
| P PasqalCompany profile Pasqal develops quantum processors that use laser-controlled neutral atoms, with systems and algorithms for industrial and research customers. Pasqal develops quantum processors that use laser-controlled neutral atoms, with systems and algorithms for industrial and research customers. | €170M | Private financingUndisclosed | Hardware | France | Investors | |
| T Provides AI-powered site reliability engineering for enterprise-grade SRE | Undisclosed | StrategicUndisclosed | AI | United States | Investors | |
| C Provides AI driven cyber readiness and resilience solutions | $16.4M | Undisclosed | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.